Cargando…
Therapeutic effects of human gingiva-derived mesenchymal stromal cells on murine contact hypersensitivity via prostaglandin E(2)–EP(3) signaling
BACKGROUND: The immunomodulatory and anti-inflammatory functions of human gingiva-derived mesenchymal stromal cells (GMSCs) have been demonstrated in contact hypersensitivity (CHS) models; however, their therapeutic effect during the late phase of CHS has been poor. METHODS: The murine CHS model was...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969691/ https://www.ncbi.nlm.nih.gov/pubmed/27484807 http://dx.doi.org/10.1186/s13287-016-0361-9 |
_version_ | 1782445824414842880 |
---|---|
author | Li, Pei Zhao, Yuming Ge, Lihong |
author_facet | Li, Pei Zhao, Yuming Ge, Lihong |
author_sort | Li, Pei |
collection | PubMed |
description | BACKGROUND: The immunomodulatory and anti-inflammatory functions of human gingiva-derived mesenchymal stromal cells (GMSCs) have been demonstrated in contact hypersensitivity (CHS) models; however, their therapeutic effect during the late phase of CHS has been poor. METHODS: The murine CHS model was induced by applying oxazolone to the ears of mice. Mesenchymal stromal cells were applied via two methods (intravenous or local injection) at three time points: 1 day before sensitization, 1 day before challenge, or 1 h after challenge. Prostaglandin E(2) (PGE(2)) and sulprostone were administered subcutaneously 1 h after challenge. RESULTS: The application of GMSCs, bone marrow mesenchymal stem cells, and adipose-derived stem cells all effectively suppressed CHS; however, GMSC treatment exhibited the greatest efficacy. Local injection of GMSCs led to a more marked attenuation of CHS compared with intravenous injection, especially during the late phase of CHS, and this manifested as decreased infiltration of inflammatory cells, suppression of the levels of various proinflammatory cytokines, reconstruction of the disrupted Th1/Th2 balance, and upregulation of regulatory T cells in the allergen contact areas. Pretreatment with indomethacin significantly abrogated the GMSC-mediated immunosuppressive effects, while PGE(2) application reversed the effects of indomethacin pretreatment of GMSCs. Moreover, GMSC administration promoted the expression of EP(3), a prostaglandin E receptor, and the application of sulprostone, an agonist of EP(3), significantly attenuated CHS to a similar degree as that of GMSC administration. CONCLUSIONS: GMSCs have reproducible and powerful immunomodulatory functions. Local injection of GMSCs is the superior mode for therapeutic application. PGE(2)–EP(3) signaling plays an important role in the immunomodulatory functions of GMSCs in murine CHS. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13287-016-0361-9) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4969691 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-49696912016-08-03 Therapeutic effects of human gingiva-derived mesenchymal stromal cells on murine contact hypersensitivity via prostaglandin E(2)–EP(3) signaling Li, Pei Zhao, Yuming Ge, Lihong Stem Cell Res Ther Research BACKGROUND: The immunomodulatory and anti-inflammatory functions of human gingiva-derived mesenchymal stromal cells (GMSCs) have been demonstrated in contact hypersensitivity (CHS) models; however, their therapeutic effect during the late phase of CHS has been poor. METHODS: The murine CHS model was induced by applying oxazolone to the ears of mice. Mesenchymal stromal cells were applied via two methods (intravenous or local injection) at three time points: 1 day before sensitization, 1 day before challenge, or 1 h after challenge. Prostaglandin E(2) (PGE(2)) and sulprostone were administered subcutaneously 1 h after challenge. RESULTS: The application of GMSCs, bone marrow mesenchymal stem cells, and adipose-derived stem cells all effectively suppressed CHS; however, GMSC treatment exhibited the greatest efficacy. Local injection of GMSCs led to a more marked attenuation of CHS compared with intravenous injection, especially during the late phase of CHS, and this manifested as decreased infiltration of inflammatory cells, suppression of the levels of various proinflammatory cytokines, reconstruction of the disrupted Th1/Th2 balance, and upregulation of regulatory T cells in the allergen contact areas. Pretreatment with indomethacin significantly abrogated the GMSC-mediated immunosuppressive effects, while PGE(2) application reversed the effects of indomethacin pretreatment of GMSCs. Moreover, GMSC administration promoted the expression of EP(3), a prostaglandin E receptor, and the application of sulprostone, an agonist of EP(3), significantly attenuated CHS to a similar degree as that of GMSC administration. CONCLUSIONS: GMSCs have reproducible and powerful immunomodulatory functions. Local injection of GMSCs is the superior mode for therapeutic application. PGE(2)–EP(3) signaling plays an important role in the immunomodulatory functions of GMSCs in murine CHS. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13287-016-0361-9) contains supplementary material, which is available to authorized users. BioMed Central 2016-08-02 /pmc/articles/PMC4969691/ /pubmed/27484807 http://dx.doi.org/10.1186/s13287-016-0361-9 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Li, Pei Zhao, Yuming Ge, Lihong Therapeutic effects of human gingiva-derived mesenchymal stromal cells on murine contact hypersensitivity via prostaglandin E(2)–EP(3) signaling |
title | Therapeutic effects of human gingiva-derived mesenchymal stromal cells on murine contact hypersensitivity via prostaglandin E(2)–EP(3) signaling |
title_full | Therapeutic effects of human gingiva-derived mesenchymal stromal cells on murine contact hypersensitivity via prostaglandin E(2)–EP(3) signaling |
title_fullStr | Therapeutic effects of human gingiva-derived mesenchymal stromal cells on murine contact hypersensitivity via prostaglandin E(2)–EP(3) signaling |
title_full_unstemmed | Therapeutic effects of human gingiva-derived mesenchymal stromal cells on murine contact hypersensitivity via prostaglandin E(2)–EP(3) signaling |
title_short | Therapeutic effects of human gingiva-derived mesenchymal stromal cells on murine contact hypersensitivity via prostaglandin E(2)–EP(3) signaling |
title_sort | therapeutic effects of human gingiva-derived mesenchymal stromal cells on murine contact hypersensitivity via prostaglandin e(2)–ep(3) signaling |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969691/ https://www.ncbi.nlm.nih.gov/pubmed/27484807 http://dx.doi.org/10.1186/s13287-016-0361-9 |
work_keys_str_mv | AT lipei therapeuticeffectsofhumangingivaderivedmesenchymalstromalcellsonmurinecontacthypersensitivityviaprostaglandine2ep3signaling AT zhaoyuming therapeuticeffectsofhumangingivaderivedmesenchymalstromalcellsonmurinecontacthypersensitivityviaprostaglandine2ep3signaling AT gelihong therapeuticeffectsofhumangingivaderivedmesenchymalstromalcellsonmurinecontacthypersensitivityviaprostaglandine2ep3signaling |